Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Dose of Atorvastatin for Preventing Cerebral Vascular Wall Damage in Patients Undergoing Mechanical Thrombectomy

NCT05912686 is registered in ClinicalTrials.gov with Zhongda Hospital as lead sponsor.

NCT NCT05912686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05912686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Dose of Atorvastatin for Preventing Cerebral Vascular Wall Damage in Patients Undergoing Mechanical Thrombectomy
Lead sponsor
Zhongda Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
July 1, 2023
Completion date
July 31, 2026
Enrollment
162 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, mechanical thrombectomy